![]() ![]() ![]() Nat Rev Mol Cell Biol 4(9):733–738ĭe Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL (1998) Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Trends Neurosci 13(5):184–188īos JL (2003) Epac: a new cAMP target and new avenues in cAMP research. Montminy MR, Gonzalez GA, Yamamoto KK (1990) Regulation of cAMP-inducible genes by CREB. Mayr B, Montminy M (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Walsh DA, Perkins JP, Krebs EG (1968) An adenosine 3’, 5’-monophosphate-dependant protein kinase from rabbit skeletal muscle. J Biol Chem 269(24):16554–16558īender AT, Beavo JA (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Kawabe J, Iwami G, Ebina T, Ohno S, Katada T, Ueda Y, Homcy CJ, Ishikawa Y (1994) Differential activation of adenylyl cyclase by protein kinase C isoenzymes. Biochemistry 40(6):1702–1709ĭing Q, Gros R, Gray ID, Taussig R, Ferguson SS, Feldman RD (2004) Raf kinase activation of adenylyl cyclases: isoform-selective regulation. Tan CM, Kelvin DJ, Litchfield DW, Ferguson SS, Feldman RD (2001) Tyrosine kinase-mediated ser phosphorylation of adenylyl cyclase. Sunahara RK, Taussig R (2002) Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. Annu Rev Physiol 69:511–534Ĭooper DM (2003) Regulation and organization of adenylyl cyclases and cAMP. Premont RT, Gainetdinov RR (2007) Physiological roles of G protein–coupled receptor kinases and arrestins. ![]() Gilman A (1987) G Proteins: transducers of receptor-generated signals. Endocr Rev 21(1):90–113ĭohlman HG, Thorner J, Caron MG, Lefkowitz RJ (1991) Model systems for the study of seven-transmembrane-segment receptors. Gether U (2000) Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Proc Am Thorac Soc 2(4):386–390 discussion 394–385īockaert J, Pin JP (1999) Molecular tinkering of G protein-coupled receptors: an evolutionary success. Karin M (2005) Inflammation-activated protein kinases as targets for drug development. Greten FR, Karin M (2004) The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer. Vallabhapurapu S, Karin M (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Tasken K, Ruppelt A (2006) Negative regulation of T-cell receptor activation by the cAMP-PKA-Csk signalling pathway in T-cell lipid rafts. Serezani CH, Ballinger MN, Aronoff DM, Peters-Golden M (2008) Cyclic AMP: master regulator of innate immune cell function. Kammer GM (1988) The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Curr Opin Cell Biol 3(2):213–217īourne HR, Lichtenstein LM, Melmon KL, Henney CS, Weinstein Y, Shearer GM (1974) Modulation of inflammation and immunity by cyclic AMP. McKnight GS (1991) Cyclic AMP second messenger systems. These findings not only open up exciting new research avenues but also reveal novel opportunities for the design of more selective, NF-κB-targeting, anti-inflammatory drugs. Importantly, several novel players in the cAMP/NF-κB connection, which selectively direct cAMP action, have been recently identified. Indeed, cAMP actions appear to be highly cell type- and context-dependent. Paradoxically, recent reports indicate that cAMP, via its main effector, the protein kinase A (PKA), also promotes NF-κB activity. A number of fundamental molecular mechanisms, contributing to the overall inhibitory actions of cAMP on NF-κB function, are well established. NF-κB plays a crucial role in switching on the gene expression of a plethora of inflammatory and immune mediators, and as such is one of the master regulators of the immune response and a key target for anti-inflammatory drug design. These actions have been attributed in part to the ability of cAMP-induced signals to interfere with the function of the proinflammatory transcription factor Nuclear Factor-kappaB (NF-κB). It has been known for several decades that cyclic AMP (cAMP), a prototypical second messenger, transducing the action of a variety of G-protein-coupled receptor ligands, has potent immunosuppressive and anti-inflammatory actions. ![]()
0 Comments
Leave a Reply. |